📰 Harvard Bioscience News
Page 7 - Harvard Bioscience News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Harvard Bioscience. Real-time updates on events, politics, business and more.
May 2, 2023
Operator: Good day, and thank you for standing by. Welcome to Harvard Bioscience First Quarter 2023 Earnings Conference Call. Please be advised that todays conference is being recorded.
May 2, 2023
HOLLISTON, Mass., May 02, 2023 -- Harvard Bioscience, Inc. today announced that Chairman and Chief Executive Officer Jim Green will present and host one-on-one meetings with investors at the... | May 2, 2023
April 27, 2023
The company reported improved revenue in Q1.
April 26, 2023
Wednesday April 26, 2023 Trading Desk: (312) 236-8907 TODAY’S GAME PLAN: from the trading desk, this is not research DATA/HEADLINES 8:30ET Advance Goods Trade Balance, Wholesale Inventories MoM, Retail Inventories MoM, Durable Goods Orders; 1:00ET 5 year note auction Fed members on communication blackout period ahead of May 3 policy announcement TODAY’S HIGHLIGHTS: GOP DEBT
April 25, 2023
Q1 Revenues of $30 million up 4% over prior year periodQ1 GAAP Operating Income of $1.7 million up from a loss of $6.7 million prior yearQ1 Adjusted Operating Income of $4.4 million up from $2.4 million
April 25, 2023
HOLLISTON, Mass. (AP) — HOLLISTON, Mass. (AP) — Harvard Bioscience Inc. (HBIO) on Tuesday reported net income of $622,000 in its first quarter. On a per-share basis, the Holliston, Massachusetts-based company said it had profit of 1 cent.
April 25, 2023
25.04.2023 - Q1 Revenues of $30 million up 4% over prior year periodQ1 GAAP Operating Income of $1.7 million up from a loss of $6.7 million prior yearQ1 Adjusted Operating Income of $4.4 million up from $2.4 million prior year HOLLISTON, Mass., April 25, 2023 ...
April 23, 2023
Harvard Bioscience (NASDAQ:HBIO – Get Rating) is set to announce its earnings results before the market opens on Tuesday, April 25th. Analysts expect the company to announce earnings of $0.05 per share for the quarter. Investors that wish to listen to the company’s conference call can do so using this link. Harvard Bioscience Stock Up […]
April 18, 2023
Monarch Partners Asset Management LLC reduced its stake in Harvard Bioscience, Inc. (NASDAQ:HBIO – Get Rating) by 23.4% in the 4th quarter, according to its most recent filing with the Securities & Exchange Commission. The fund owned 613,837 shares of the medical instruments supplier’s stock after selling 187,422 shares during the quarter. Monarch Partners Asset […]